The table contains 4 products whose active ingredient are classified under the same pharmacologic class Amyloid Beta-directed Antibody [EPC].
|
NDC |
Proprietary Name |
Non-Proprietary Name |
Dosage Form |
Route Name |
Company Name |
Status |
| 62856-212 | Leqembi | Non-Proprietary Name: Lecanemab | Injection, Solution | Intravenous | Eisai Inc. | ACTIVE |
| 62856-215 | Leqembi | Non-Proprietary Name: Lecanemab | Injection, Solution | Intravenous | Eisai Inc. | ACTIVE |
| 64406-101 | Aduhelm | Non-Proprietary Name: Aducanumab | Injection, Solution | Intravenous | Biogen Inc. | ACTIVE |
| 64406-102 | Aduhelm | Non-Proprietary Name: Aducanumab | Injection, Solution | Intravenous | Biogen Inc. | ACTIVE |